Global News

Clinverse, OmniComm Systems partner

Wednesday, September 4, 2013 12:23 PM

Clinverse, a global technology and eclinical commerce network for clinical trials, has formed a strategic partnership with OmniComm Systems, a provider of EDC solutions.

More... »

Baxter, Coherus Biosciences collaborate

Wednesday, September 4, 2013 12:09 PM

Baxter International and Coherus Biosciences, a San Francisco Bay area-based clinical stage, pure-play biosimilar company, have entered into an exclusive collaboration to develop and commercialize a biosimilar to etanercept for Europe, Canada and Brazil. Biosimilars are intended to be used in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases and have the potential to reduce costs and expand patient access.

More... »

Dropout rates for phase I oncology trials remain under 10%

Wednesday, September 4, 2013 12:04 PM

The overall dropout rate for oncology phase I trials is only 8%, according to a study by Cutting Edge Information. However, dropout rates tend to rise as the number of required visits increases.

More... »

Wellcome Trust, KU Leuven, Janssen collaborate

Wednesday, September 4, 2013 11:53 AM

Wellcome Trust, Janssen and KU Leuven are collaborating for dengue antiviral drugs. The collaboration will build on an existing three-year drug discovery program at the Rega Institute and the Center for Drug Design and Discovery (CD3) at KU Leuven, supported by a Wellcome Trust Seeding Drug Discovery Award.

More... »

The CenterWatch Monthly, September 2013

Tuesday, September 3, 2013 08:00 AM

Sponsors look to collaborate on comparator drugs

More... »

Bosch Healthcare, Remedy Health Media partner to enhance patient engagement

Friday, August 30, 2013 02:26 PM

Robert Bosch Healthcare Systems, a provider of telehealth systems, and Remedy Health Media, a provider of clinical resources and wellness tools, have partnered to develop and market a suite of web-based products and solutions focused on supporting better patient engagement in telehealth and compliance with medical care. The partnership combines Bosch’s evidence-based telehealth solutions for chronic medical and mental health conditions with Remedy’s design and development of patient engagement models to improve patients’ compliance with medical care and self-management skills.

More... »

Humana, Lilly collaborate to improve healthcare outcomes

Friday, August 30, 2013 02:24 PM

Humana, a Louisville, Ky.-based health and well-being company, and Eli Lilly have signed a multi-year collaboration to improve the healthcare of their members and patients.

More... »

ObsEva, Merck Serono ink license agreement

Friday, August 30, 2013 02:23 PM

ObsEva, a Swiss-based, specialty biopharmaceutical company, signed a licensing agreement with Merck Serono, the biopharmaceutical division of Germany-based Merck, granting ObsEva worldwide development and commercialization rights to certain Merck Serono compounds for preterm labor. The details of the agreement were not disclosed. The funding will allow ObsEva to undertake the development of these compounds.

More... »

Zealand, Eli Lilly collaborate on peptide drug R&D

Friday, August 30, 2013 02:20 PM

Zealand Pharma, a Denmark-based biotechnology company, announced an exclusive peptide drug R&D collaboration with Eli Lilly.

More... »

OPKO acquires Prolor Biotech

Friday, August 30, 2013 02:19 PM

OPKO Health, a multinational biopharmaceutical and diagnostics company, has acquired Prolor Biotech, a clinical-stage biopharmaceutical company. Stockholders of Prolor will receive 0.9951 shares of OPKO common stock for each share of Prolor common stock. The stockholders of both companies approved all proposals presented at their respective stockholder meetings.

More... »